MetaCap

Evolus (EOLS) News

NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.52-0.48 (-6.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EOLS news summary

We found 7 recent headlines mentioning Evolus (EOLS): 0 in the past week and 6 in the past 30 days, most often from PR Newswire, Nasdaq, Business Wire. EOLS is making an outsized move today, down 6.86% at $6.52, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS", was published by PR Newswire on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Evolus headlines

Stocks mentioned alongside EOLS

Compare EOLS